Advertisement
Frazier Lifesciences Acqu... (FLACU)
Frazier Lifesciences Acquisition Statistics
Share Statistics
Frazier Lifesciences Acquisition has - shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | - |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 17.77 and the forward PE ratio is null. Frazier Lifesciences Acquisition's PEG ratio is 0.
| PE Ratio | 17.77 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 1.31 |
| P/FCF Ratio | -1250.72 |
| PEG Ratio | 0 |
Enterprise Valuation
Frazier Lifesciences Acquisition has an Enterprise Value (EV) of 171.85M.
| EV / Sales | 0 |
| EV / EBITDA | 40.97 |
| EV / EBIT | -1241.86 |
| EV / FCF | -1241.86 |
Financial Position
The company has a current ratio of 6.7, with a Debt / Equity ratio of 0.
| Current Ratio | 6.7 |
| Quick Ratio | 6.7 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | -84.56 |
Financial Efficiency
Return on Equity is 7.4% and Return on Invested Capital is -2.42%.
| Return on Equity | 7.4% |
| Return on Assets | 6.98% |
| Return on Invested Capital | -2.42% |
| Revenue Per Employee | $- |
| Profits Per Employee | $- |
| Employee Count | undefined |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -5.56M |
| Effective Tax Rate | -133.08% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is 0, so Frazier Lifesciences Acquisition's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 10.07 |
| 200-Day Moving Average | null |
| Relative Strength Index (RSI) | 41.87 |
| Average Volume (20 Days) | 4.49K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -1.37M |
| Net Income | 9.74M |
| EBITDA | 4.19M |
| EBIT | 4.19M |
| Earnings Per Share (EPS) | 0.55 |
Balance Sheet
The company has 1.23M in cash and 0 in debt, giving a net cash position of 1.23M.
| Cash & Cash Equivalents | 1.23M |
| Total Debt | 0 |
| Net Cash | 1.23M |
| Retained Earnings | -6.36M |
| Total Assets | - |
| Working Capital | - |
Cash Flow
In the last 12 months, operating cash flow was -138.38K and capital expenditures 0, giving a free cash flow of -138.38K.
| Operating Cash Flow | -138.38K |
| Capital Expenditures | 0 |
| Free Cash Flow | -138.38K |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FLACU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 5.63% |
| FCF Yield | -0.08% |
Analyst Forecast
Currently there are no analyst rating for FLACU.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | null |
| Piotroski F-Score | null |